FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385058004: Effervescent tablet (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479320015 Effervescent tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2660325013 Effervescent tablet (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Effervescent tablet Is a A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    Effervescent tablet Is a Oral tablet false Inferred relationship Some
    Effervescent tablet Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by swallowing. false Inferred relationship Some
    Effervescent tablet Has dose form administration method (attribute) A method of administration of a dose form by taking into the mouth and allowing to pass down the throat. false Inferred relationship Some
    Effervescent tablet Has dose form transformation (attribute) No transformation false Inferred relationship Some
    Effervescent tablet Has dose form release characteristic (attribute) A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties. false Inferred relationship Some
    Effervescent tablet Has basic dose form (attribute) A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Calcium carbonate 1.25 g effervescent oral tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Calcium compound 400mg effervescent tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Calcium compound 1000mg effervescent tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Product containing precisely calcium gluconate 1 gram/1 each conventional release effervescent oral tablet (clinical drug) Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Dioralyte effervescent tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Product containing precisely potassium chloride 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Potassium bicarbonate+potassium chloride effervescent tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Potassium 6.5mmol effervescent tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Ranitidine (as ranitidine hydrochloride) 75 mg effervescent oral tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Ranitidine (as ranitidine hydrochloride) 300 mg effervescent oral tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some
    Phosphate compound 16.1mmol effervescent tablet Has manufactured dose form False Effervescent tablet Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start